Disappearance of the inhibitory effect of neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in rats with chronic pain.
Aniline Compounds
/ pharmacology
Animals
Chronic Pain
/ drug therapy
Corticotropin-Releasing Hormone
/ metabolism
Male
Membrane Potentials
/ drug effects
Neurons
/ drug effects
Neuropeptide Y
/ metabolism
Nucleus Accumbens
/ drug effects
Pyrimidines
/ pharmacology
Rats, Sprague-Dawley
Septal Nuclei
/ drug effects
Bed nucleus of the stria terminalis
Chronic pain
Emotion
Mesolimbic reward system
Neuropeptide Y
Journal
Neuroscience letters
ISSN: 1872-7972
Titre abrégé: Neurosci Lett
Pays: Ireland
ID NLM: 7600130
Informations de publication
Date de publication:
29 05 2020
29 05 2020
Historique:
received:
24
01
2020
revised:
25
03
2020
accepted:
04
04
2020
pubmed:
13
4
2020
medline:
18
5
2021
entrez:
13
4
2020
Statut:
ppublish
Résumé
We recently showed that the mesolimbic dopaminergic system was tonically suppressed during chronic pain by enhanced corticotropin releasing factor (CRF) signaling within the dorsolateral bed nucleus of the stria terminalis (dlBNST), and that inhibition of intra-dlBNST CRF signaling restored the mesolimbic dopaminergic system function. Specifically, bilateral intra-dlBNST injections of the CRF type 1 receptor antagonist NBI27914 increased intra-nucleus accumbens dopamine release and induced reward-related behaviors in rats with chronic pain. Here, we used a conditioned place preference (CPP) test to explore whether intra-dlBNST injections of neuropeptide Y (NPY) restored the mesolimbic reward system function in chronic pain rats, because we previously showed that NPY had an effect opposite to that of CRF in dlBNST neurons. Specifically, CRF depolarized type II dlBNST neurons whereas NPY hyperpolarized them. However, unexpectedly, intra-dlBNST NPY injections had no effect on CPP test outcomes. Then, we compared the effects of NPY on the membrane potentials of type II dlBNST neurons of sham-operated control rats and those of chronic pain animals. Whole-cell patch-clamp electrophysiology revealed that NPY hyperpolarized type II dlBNST neurons in the sham-operated group. By contrast, in the chronic pain group, NPY did not hyperpolarize, but rather depolarized, type II dlBNST neurons. These results indicate that NPY no longer hyperpolarizes type II dlBNST neurons in rats with chronic pain, therefore it does not reverse the excitatory effects of CRF. This may be why intra-dlBNST injections of NPY into chronic pain rats did not exhibit a rewarding effect in the CPP test, whereas intra-dlBNST injections of NBI27914 did. This is the first study to demonstrate a chronic pain-induced neuroplastic change in NPY signaling in the dlBNST. Such a change may be involved in the dysfunction of the mesolimbic reward system under the chronic pain condition.
Identifiants
pubmed: 32278943
pii: S0304-3940(20)30228-7
doi: 10.1016/j.neulet.2020.134958
pii:
doi:
Substances chimiques
2-methyl-4-(N-propyl-N-cycloproanemethylamino)-5-chloro-6-(2,4,6-trichloranilino)pyrimidine
0
Aniline Compounds
0
Neuropeptide Y
0
Pyrimidines
0
Corticotropin-Releasing Hormone
9015-71-8
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
134958Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.